Finance

Second quarter 2002 revenue increased 164%

Published in Hepatitis Weekly, September 16th, 2002

Isis Pharmaceuticals, Inc., (ISIS), announced that its total revenue for the second quarter 2002 increased by $12.5 million, or 164% over that reported for the same period in 2001.

The increase in revenue contributed to a 25% decrease in loss from operations to $12.3 million for the second quarter 2002 from $16.5 million for the same period in 2001. The increase in revenue was partially offset by increases in operating expenses in the second quarter 2002 compared with the same period in 2001.

The company's net loss applicable to common stock for the second quarter was $21.2 million, or $0.39 per share, compared with a net loss applicable to common...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry